🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China flag China · Delayed Price · Currency is CNY
4.070
-0.050 (-1.21%)
Nov 20, 2026, 3:00 PM CST

SHA:600572 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
6,7366,3826,4266,6525,9456,531
Other Revenue
91.4391.4389.0280.5954.9537.67
6,8286,4736,5156,7336,0006,568
Revenue Growth
3.80%-0.64%-3.23%12.21%-8.64%11.15%
Cost of Revenue
3,0883,0513,1012,8352,4702,626
Gross Profit
3,7403,4223,4143,8973,5313,942
Selling, General & Admin
2,6832,5642,4802,8322,5812,964
Research & Development
240.62262.22300.02298.09195.72202.49
Other Operating Expenses
128.4365.4352.8-38.4962.9964.65
Operating Expenses
3,0592,8932,8343,0932,8403,268
Operating Income
680.94529.22580.51804.32690.41674.18
Interest Expense
-4.21-7.79-20.79-36.4-49.47-73.22
Interest & Investment Income
98.9795.48101.92135.2789.352,611
Currency Exchange Gain (Loss)
-1.75-1.755.223.09-1.110.06
Other Non Operating Income (Expenses)
-11.79-11.16-1.65-21.98-3.76-9.31
EBT Excluding Unusual Items
762.16604665.22884.3725.423,203
Gain (Loss) on Sale of Investments
-156.5425.6430.27-146.04-238.23-714.69
Gain (Loss) on Sale of Assets
-0.074.8916.9135.6836.0242.22
Asset Writedown
-23.69-26.81-1.82-7.18-1.84-95.71
Other Unusual Items
66.7437.4569.360.9368.6492.55
Pretax Income
648.6645.17779.94767.69590.012,527
Income Tax Expense
170.45153.62121.5992.97129.89391.13
Earnings From Continuing Operations
478.16491.55658.35674.72460.122,136
Minority Interest in Earnings
-21.42-17.19-35.94-83.15-102-118.31
Net Income
456.74474.36622.42591.57358.122,017
Net Income to Common
456.74474.36622.42591.57358.122,017
Net Income Growth
-33.61%-23.79%5.21%65.19%-82.25%345.06%
Shares Outstanding (Basic)
2,5142,4972,4902,5722,5582,586
Shares Outstanding (Diluted)
2,5142,4972,4902,5722,5582,586
Shares Change
1.32%0.28%-3.20%0.55%-1.10%2.71%
EPS (Basic)
0.180.190.250.230.140.78
EPS (Diluted)
0.180.190.250.230.140.78
EPS Growth
-34.48%-24.00%8.70%64.29%-82.05%333.33%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,007795.35721.9689.5863.73309.8
Free Cash Flow Per Share
0.400.320.290.270.340.12
Dividend Per Share
0.1500.1500.1500.2000.1500.160
Dividend Growth
0%0%-25.00%33.33%-6.25%-
Gross Margin
54.78%52.87%52.41%57.88%58.84%60.02%
Operating Margin
9.97%8.18%8.91%11.95%11.51%10.26%
Profit Margin
6.69%7.33%9.55%8.79%5.97%30.72%
Free Cash Flow Margin
14.75%12.29%11.08%10.24%14.39%4.72%
EBITDA
1,006861.21921.471,129963.34956.65
EBITDA Margin
14.74%13.30%14.14%16.76%16.05%14.56%
D&A For EBITDA
325.25331.98340.96324.35272.93282.47
EBIT
680.94529.22580.51804.32690.41674.18
EBIT Margin
9.97%8.18%8.91%11.95%11.51%10.26%
Effective Tax Rate
26.28%23.81%15.59%12.11%22.02%15.48%
Revenue as Reported
6,8286,4736,5156,7336,0006,568